Evidence map›Paper›PMID 33340599›Full record

ArticleJournal of ethnopharmacology2021

Curcuma oil ameliorates benign prostatic hyperplasia through suppression of the nuclear factor-kappa B signaling pathway in rats.

Shanshan Wang, Yun Li, Wenzhi Li, Kun Zhang, Zhengqiang Yuan, Yina Cai, Kuncheng Xu, Jinrong Zhou, Zhiyun Du

Open access · greenAbstract read
In one paragraph

Article in Journal of ethnopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. The Combination ofThe world journal of men's health · 2025
    Article
  5. The combination of water extracts ofNutrition research and practice · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Shanshan WangSchool of Biomedical and Phamaceutical Sciences, Gunagdong University of Technology, Guangzhou, 511400, China.
Yun LiR&D Centre, Infinitus (China) Company Ltd, Guangzhou, China.
Wenzhi LiR&D Centre, Infinitus (China) Company Ltd, Guangzhou, China.
Kun ZhangSchool of Biomedical and Phamaceutical Sciences, Gunagdong University of Technology, Guangzhou, 511400, China.
Zhengqiang YuanSchool of Biomedical and Phamaceutical Sciences, Gunagdong University of Technology, Guangzhou, 511400, China.
Yina CaiSchool of Biomedical and Phamaceutical Sciences, Gunagdong University of Technology, Guangzhou, 511400, China.
Kuncheng XuSchool of Biomedical and Phamaceutical Sciences, Gunagdong University of Technology, Guangzhou, 511400, China.
Jinrong ZhouDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. Electronic address: JinrongZhou@foxmail.com.
Zhiyun DuSchool of Biomedical and Phamaceutical Sciences, Gunagdong University of Technology, Guangzhou, 511400, China; Conney Allan Biotechnology Company Ltd, Guangzhou, 510095, China. Electronic address: zhiyundu@gdut.edu.cn.
Infinitus (China) · CNBeth Israel Deaconess Medical Center · US

Funding

Oldenlandia diffusa for prostate cancer treatmentR21CA133865 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ZHOU, JIN-RONG · 2007 to 2008
$374k
NCI NIH HHS R21 CA133865
6 · The paper itself

Abstract

ethno pharmacological relevanceCurcuma longa L is traditionally used as an anti-inflammatory remedy in Chinese traditional medicine. Curcuma oil (CO), a lipophilic fraction from Curcuma longa L. has been reported to have anti-proliferative, anti-inflammatory and anti-oxidant activities. However, CO has never been investigated for its possible therapeutic effects on benign prostatic hyperplasia (BPH). AIMS OF THE STUDY: The study is thus to determine the therapeutic effects of curcuma oil on BPH and also the possible mechanism (s) of action. MATERIALS &

methodsA BPH-1 cell line and Sprague Dawley (SD) rats were used to establish BPH models in vitro and in vivo, respectively. Rats were treated by CO (2.4, 7.2 mg/kg/i.g.) and finasteride (5 mg/kg/i.g.), respectively. Histological changes were examined by hematoxylin and eosin (H&E) staining. Protein expression was analyzed for 5α-reductase (5AR), dihydrotestosterone (DHT), interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF)-α by ELISA. Ki-67, Caspase-8,-9 and -3 expressions were evaluated via immunohistochemistry (IHC).

resultsCO effectively induced apoptosis in BPH-1 cells. BPH was successfully established by administration of testosterone propionate (TP) in rats, which upregulated both 5α-reductase expression and DHT production. Importantly, TP establishment significantly stimulated the phosphorylation of p65, one subunit of NF-κB, thus led to activation of the NF-κB signaling pathway in prostatic tissues of rats. In turn, the activation of NF-κB pathway induced concomitant upregulation of proinflammatory factors IL-1β, IL-6, TNF-α, and COX-2 and significant increase of the Bcl2/Bax expression ratio for enhanced cell survival, contributing to the initiation and progression of BPH in rats. Notably, CO therapy significantly decreased prostate weight and hyperplasia in BPH-induced animals. Also CO was found to suppress the expression of 5α-reductase and thus the production of DHT, which is essential for the amelioration of BPH. More importantly, CO was shown to suppress the activation of NF-κB pathway through decreasing the expression of phosphorylated p65 and consequently reduced the inflammatory responses and cell survival in prostatic tissues, leading to the inhibition of BPH development in rats.

conclusionCurcuma oil is very effective for ameliorating BPH in rats. The underlying mechanisms involve in reduced inflammatory responses and cell survival through suppression of the NF-κB signaling pathway by CO in prostatic tissues.

Indexed as

AnimalsCell LineCell SurvivalCurcumaDisease Models, AnimalDisease ProgressionHumansInflammationMaleNF-kappa BPlant OilsProstatic HyperplasiaRatsRats, Sprague-DawleySignal TransductionNF-kappa BPlant OilsApoptosisBenign prostate hyperplasiaCurcuma oilInflammationNF-κB signaling pathway

Identifiers

PMID33340599
PMCPMC9586842
OpenAlexW3110933223

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.